DNMT3B and pancreatic neoplasm: Their analysis revealed a noticeable reduction in the expression levels of miR-29b, along with an upregulated mRNA expression of DNMT3b, within the pancreatic cancer tissues when compared to the corresponding paracancerous tissues.